News
Stocktwits on MSN57m
Replimune Stock Catches Retail Fire As Analyst Says FDA Shakeup Removes 'Major Obstacle' For Skin Cancer Drug's Potential ApprovalRetail trader buzz around Replimune Group surged Wednesday after Cantor Fitzgerald upgraded the stock to ‘Overweight’ from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback